Pharmaceutical development of medicines for use in the older population

  • Email
  • Help
Current version

Reflection paper

Deadline for comments: 31/01/2018

Reference numberEMA/CHMP/QWP/292439/2017
Published01/08/2017
KeywordsPharmaceutical development, older people, elderly, ageing, frailty, age-appropriateness, medication management, medication errors, off-label, usability
Description

The reflection paper describes aspects that medicines developers may consider when designing medicines for older people, such as selecting appropriate routes of administration and dosage forms, dosing frequency, excipients, container closure systems, devices and technologies, and user instructions in the product information. The CHMP may develop this reflection paper into regulatory or scientific guidance. 

Comments should be provided using this template. The completed comments form should be sent to qwp@ema.europa.eu.



Document history

First version

In progress

 

Reflection paper

 

 

Concept paper

Published: 01/08/2017

Deadline for comments: 31/01/2018 

 

Published: 05/04/2013


Related content


How helpful is this page?

Average rating:

 Based on 4 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
4 ratings
0 ratings
    

Tell us more